Peptides DB
Research-centric peptide and protocol reference hub
Study 5 of 5Ecnoglutide literatureVirulence · Review2026

<i>Escherichia coli</i> outer membrane vesicles: Bacterial virulence, antibiotic resistance, host interactions, and applications in biomedical platforms.

E. coli OMVs are crucial in bacterial virulence and resistance, with potential applications in biomedical fields like vaccine development.

Read at VirulenceAdd to compare

Where it sits

this study against the rest of the ecnoglutide corpus
2
Preclinical
1
Observational
0
Open-label
1
Randomised
1
Reviews · this one

Summary and findings

This review explores the role of Escherichia coli outer membrane vesicles (OMVs) in bacterial virulence, antibiotic resistance, and host interactions. It evaluates the biogenesis, molecular composition, and potential biomedical applications of OMVs. The review emphasizes the importance of understanding OMVs for developing novel strategies in infection control and therapy.

How much of this paper we could read: full text read (0.90). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as Virulence supplied them

<i>Escherichia coli</i> is a clinically significant Gram-negative pathogen, and the emergence of multidrug-resistant and highly virulent strains poses a grave threat to public health. Outer membrane vesicles (OMVs) are spherical nanostructures secreted by Gram-negative bacteria and composed of the outer membrane and a suite of encapsulated bioactive components, including proteins, lipopolysaccharides, and nucleic acids. Research indicates that OMVs play pivotal roles in pathogenic mechanisms, antimicrobial resistance transmission, and host-pathogen interactions. This review systematically elucidates the biogenesis mechanisms and molecular composition of <i>E. coli</i> OMVs while thoroughly examining their core biological functions in virulence, resistance, and immune modulation. Additionally, this review evaluates the translational potential of OMVs in vaccine development, biomolecular delivery, and tumor therapy. In summary, a comprehensive understanding of the biological properties and functions of <i>E. coli</i> OMVs is crucial for developing innovative OMV-based strategies for infection control, diagnosis, and therapy, thereby providing valuable directions for future research.

Background

Escherichia coli is a significant pathogen due to its multidrug-resistant and highly virulent strains, posing a public health threat. Outer membrane vesicles (OMVs) are secreted by Gram-negative bacteria like E. coli and are involved in various biological processes, including virulence and antibiotic resistance. Understanding the roles of OMVs is crucial for developing innovative strategies for infection control and therapy.

Methods

This is a review article that systematically examines existing literature on the biogenesis, molecular composition, and biological functions of E. coli OMVs. It also evaluates the potential applications of OMVs in biomedical fields such as vaccine development and tumor therapy.

Results

Not reported in abstract.

Interpretation

The review consolidates current knowledge on E. coli OMVs, highlighting their role in virulence and resistance. While it suggests potential biomedical applications, the lack of new experimental data limits the ability to assess clinical significance. The findings align with existing literature on the importance of OMVs in bacterial pathogenesis.

Key findings

  • OMVs are spherical nanostructures secreted by Gram-negative bacteria.
  • OMVs contain proteins, lipopolysaccharides, and nucleic acids.
  • OMVs play roles in pathogenic mechanisms and antimicrobial resistance.
  • OMVs have potential applications in vaccine development and tumor therapy.

Limitations

  • No new experimental data
  • Focuses on existing literature
  • Lacks quantitative findings

Elsewhere in the Ecnoglutide corpus

CGenome-integrated engineering of &lt;i&gt;Escherichia coli&lt;/i&gt; Nissle 1917 enables sustained gut-local biosynthesis of 5-hydroxytryptophan.Synthetic and systems biotechnology · 2026 · 5-HTP titer of 863.2 mg/L, the highest level reported in EcN-based systems.AnimalAEfficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a randomised, double-blind, placebo-controlled, phase 3 trialbiorxiv-preprint · 2025 · -1.96% HbA1c vs placebo at 24 wk with 0.6 mg ecnoglutide, n=69.HumanDFramework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update.Nature medicine · 2026DHuman embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.Nature medicine · 2026